These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5320355)

  • 1. Rifamycin SV. A review.
    Bergamini N; Fowst G
    Arzneimittelforschung; 1965 Aug; 15(8):Suppl:951-1002. PubMed ID: 5320355
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological deficiencies induced by some hydrazone derivatives of rifamycin SV.
    Păunescu E
    Rev Roum Med; 1974; 12(4):233-44. PubMed ID: 4617918
    [No Abstract]   [Full Text] [Related]  

  • 3. Action of some antibiotics on the extra-hepatic biliary tract. I. Rifamycin SV.
    Benzi G; Crema A; Frigo GM
    Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):403-12. PubMed ID: 4964590
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of an intravenous infusion of rifamycin SV on the excretion of bilirubin, bromsulphalein, and indocyanine green in man.
    Acocella G; Nicolis FB; Tenconi LT
    Gastroenterology; 1965 Nov; 49(5):521-5. PubMed ID: 5322057
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical studies with a new rifamycin derivative.
    Cohn HD
    J Clin Pharmacol J New Drugs; 1969; 9(2):118-25. PubMed ID: 4889468
    [No Abstract]   [Full Text] [Related]  

  • 7. [The antimycobacterial activity of rifamycin B diethylamide].
    Nitti V; Ninni A; Centrella G
    Arch Tisiol Mal Appar Respir; 1966 May; 21(5):359-69. PubMed ID: 5297199
    [No Abstract]   [Full Text] [Related]  

  • 8. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2.
    Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B
    Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observations on the use of rifamycin SV by aerosol in otorhinolaryngology].
    Amorelli A
    Arch Ital Laringol; 1965; 73(1):21-8. PubMed ID: 5325013
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trial of a new antibiotic rifamycin SV.
    Singh T; Mehrotra AN; Dhanda PC
    J Assoc Physicians India; 1966 Sep; 14(9):561-6. PubMed ID: 5333114
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rifampicin, a new antitubercular bactericide].
    Thibault P
    Presse Med (1893); 1970 Feb; 78(11):501-2. PubMed ID: 5418624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with Rifamycin SV].
    Angerer M; Pexa H; Neumayr A
    Wien Med Wochenschr; 1966 Dec; 116(51):1127-31. PubMed ID: 5340059
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary report on the clinical trial of a new antibiotic--Rifocin (rifamycin sv).
    Amaku EO
    West Afr Med J Niger Pract; 1968 Dec; 17(6):281-2 passim. PubMed ID: 4883474
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of erythromycin, various tetracyclines and rifomycin SV, on extrahepatic bile ducts].
    Benzi G; Frigo GM; Arrigoni E
    Boll Chim Farm; 1968 Aug; 107(8):477-86. PubMed ID: 4976427
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of rifamycin SV on pigment excretion in rats.
    Acocella G; Billing BH
    Gastroenterology; 1965 Nov; 49(5):526-30. PubMed ID: 5851728
    [No Abstract]   [Full Text] [Related]  

  • 16. [Research on the antimitotic action of rifamycin SV on erythropoietic cells].
    Morandini GC; Moreo GC; Rossi A
    G Ital Mal Torace; 1966; 20(6):336-43. PubMed ID: 5997778
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the passage into the anterior chamber of rifamycin SV administered by venous perfusion].
    Milano C
    Boll Soc Ital Biol Sper; 1966 Feb; 42(3):102-4. PubMed ID: 5945185
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
    Dhople AM; Dimova V
    Arzneimittelforschung; 1996 Feb; 46(2):210-2. PubMed ID: 8720317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental research on the organotropism at the maternal and fetal level of rifamycin SV].
    Bertè E; Moncalvo F
    G Ital Tuberc Mal Torace; 1965; 19(6):248-51. PubMed ID: 5893317
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the bactericidal activity of a series of rifampicins against Mycobacterium leprae.
    Pattyn SR
    Arzneimittelforschung; 1982; 32(1):15-7. PubMed ID: 7037013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.